Low-density lipoprotein- cholesterol and its relation to epicardial fat volume in patients with type II diabetes mellitus

Authors

  • Asmaa A. Hasan
  • Ghada M. S. Ahmed
  • Bassem M. Abdel Hady
  • Inass H. Ahmed
  • Entesar O. El Saghier
  • Marwa F. M. El Sayed
  • Lamiaa H. Azel
  • Marwa A, Mohamed
  • Ola I. Saleh
  • Randa S. E. Taha
  • Mona A. Raafat
  • Ola H. Abd Elaziz

DOI:

https://doi.org/10.31989/bchd.v6i11.1235

Abstract

Objectives: This study aimed to compare EFV between diabetic and non-diabetic subjects in patients with clinical indications of CCTA and test the correlation between low-density lipoprotein-cholesterol (LDL-C) and EFV in type 2 diabetic (T2DM) patients.

Methods: This study was conducted on 103 cases with chest pain and intermediate risk probability for CAD and was scheduled for CT coronary angiography divided into 47 diabetic patients and 56 non-diabetic patients. The total serum cholesterol, LDL-C, TG, and HDL-C levels were analyzed for each patient. MDCT to assess CACS and EFV for patients included in the study. 

Results: The results showed thatplasma total cholesterol, TG, and LDL-C were higher with decreased HDL in the diabetic patient. EFV was significantly higher in diabetic patients (54.5±14.9 vs 44.7±7.7, p <0.02). EFV had a significant  Linear correlation with plasma total cholesterol, LDL-C, and TG. In contrast, there is a significant negative correlation between EFV and HDL-c. EFV was significantly correlated with ca score (EFV was higher in diabetic patients with greater CAC score). 

Conclusion: EFV is rising in type II diabetic patients, especially those with high ca scores, and correlates well to their characteristic hyperlipidemia, especially LDL-C. So, all diabetic patients must be started on primary prevention against LDL-C to reduce the risk of atherosclerosis. 


Keywords: Type II DM, Epicardial fat volume, LDL-c.

Downloads

Published

2023-11-24

Issue

Vol. 6 No. 11 (2023): November 2023

Section

Research Articles

License

Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request. 

 

Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.